The original version of this article unfortunately contained a mistake. The following correction has therefore been made in the original: The spelling of Ursula La Rocca’s name was incorrect. The corrected author list is given above. The original article has been corrected.
Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience (Bone Marrow Transplantation, (2021), 56, 6, (1455-1457), 10.1038/s41409-020-01174-w) / Bruzzese, A.; Assanto, G. M.; Diverio, D.; Quattrocchi, L.; Carmini, D.; La Rocca, U.; De Propris, M. S.; Trisolini, S. M.; Brescini, M.; Galassi, G.; Barberi, W.; Iori, A. P.. - In: BONE MARROW TRANSPLANTATION. - ISSN 0268-3369. - 56:6(2021), pp. 1482-1482. [10.1038/s41409-021-01242-9]
Correction to: Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience (Bone Marrow Transplantation, (2021), 56, 6, (1455-1457), 10.1038/s41409-020-01174-w)
Bruzzese A.;Assanto G. M.;Quattrocchi L.;La Rocca U.;De Propris M. S.;Brescini M.;Galassi G.;Barberi W.;Iori A. P.
2021
Abstract
The original version of this article unfortunately contained a mistake. The following correction has therefore been made in the original: The spelling of Ursula La Rocca’s name was incorrect. The corrected author list is given above. The original article has been corrected.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
